CNS Pharmaceuticals | Press Releases

Overview Financials & Filings Press Releases Events Corporate Governance Stock Information FAQS

Press Releases

Title

Date

20 February, 2025

CNS Pharmaceuticals to Present at the 18th Annual European Life Sciences CEO Forum

19 February, 2025

CNS Pharmaceuticals Inc. Participates in the Virtual Investor Top 5 for '25 On Demand Conference

19 February, 2025

Virtual Investor Top 5 for '25 Conference Hosted by JTC Now Available On Demand

19 February, 2025

CNS Pharmaceuticals Announces Reverse Stock Split

18 February, 2025

CNS Pharmaceuticals to Present at 6th Glioblastoma Drug Development Summit

10 February, 2025

CNS Pharmaceuticals to Present at the BIO CEO & Investor Conference

05 December, 2024

CNS Pharmaceuticals to Host Virtual Analyst & Investor Day on December 11 2024

25 November, 2024

CNS Pharmaceuticals Presents Update from Ongoing Potentially Pivotal Study of Berubicin Compared with Lomustine in Adult Patients with Recurrent GBM WHO Grade IV After Failure of Standard First Line Therapy

There are no press releases that match the selected filters.

View More

Stay Updated

All Press Releases
All SEC Filings
End of Day Stock Data
Weekly

At least one type of alert must be selected.

An email address is required.

Your email alerts were set.

The following alerts could not be set: